• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 488082 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418935542 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418935542 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Buyers Accumulating Shares of Amarin on 1.6x Above-Average Volume (AMRN)

Published on Fri, 04/26/2013 - 13:16
By Peter Chu

Amarin shares are trading on heavy volume today, having risen 5.9% to $6.77. Approximately 5.4 million shares have changed hands today vs. average 30-day volume of 3.4 million shares. Unusually high volume can signify a potential turning point or validate a breakout.

In the past 52 weeks, shares of Amarin have traded between a low of $6.34 and a high of $15.96 and are now at $6.77, which is 7% above that low price. The 200-day and 50-day moving averages have moved 1.22% lower and 1.41% lower over the past week, respectively.

Amarin (NASDAQ:AMRN) has potential upside of 125.8% based on a current price of $6.77 and analysts' consensus price target of $15.29. The stock should find initial resistance at its 50-day moving average (MA) of $7.78 and further resistance at its 200-day MA of $10.48.

Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Shares of MoSys Fall Below Previous 52-W...

MoSys (NASDAQ:MOSY) traded today at a new 52-week low of $1.50. So far today approxima ...

Molina Healthcare Looks to Continue to T...

Shares of Molina Healthcare (NYSE:MOH) traded at a new 52-week high today of $53.59. S ...

3M Looks to Continue to Trade Above its ...

Shares of 3M (NYSE:MMM) traded at a new 52-week high today of $164.04. So far today ap ...

Recent 52-Week High Exceeded in Shares o...

MarketAxess Holdings (NASDAQ:MKTX) traded at a new 52-week high today of $71.79. This ...

Shares of Mednax Rise to a New 52-Week H...

Mednax (NYSE:MD) traded at a new 52-week high today of $66.71. So far today approximat ...

Recent 52-Week High Exceeded in Shares o...

Masco (NYSE:MAS) traded at a new 52-week high today of $25.10. Approximately 3.1 milli ...

Watch for Continued Gains in Shares of M...

Macerich (NYSE:MAC) traded at a new 52-week high today of $82.84. Approximately 659,00 ...

Leggett & Platt: The Winning Streak Cont...

Leggett & Platt (NYSE:LEG) traded today at a new 52-week high of $42.48. So far today ...